课题基金 / 基金详情

COMPASSIONATE USE OF INTRAVENOUS ILOPROST

COMPASSIONATE USE OF INTRAVENOUS ILOPROST
同情地使用静脉注射伊洛前列素
批准号：
3850291
负责人：
JOHN M. PORTER
金额：
$0.0万
依托单位：
OREGON HEALTH & SCIENCE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3850291
关键词：
Raynaud's disease cardiovascular disorder chemotherapy human subject human therapy evaluation iloprost intravenous administration ischemia scleroderma

项目摘要

项目成果

JOHN M. PORTER的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This protocol is an adjunct to Protocol #314. The drug company has made available Iloprost, in the same dose and the same administration as in the randomized study on a compassionate use basis for selected patients who have either Raynaud's syndrome or systemic sclerosis and ischemic ulcers of the upper extremity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CHRONIC ADMINISTRATION OF CILOSTAZOL IN PATIENTS WITH INTERMITTENT CLAUDICATION
DIAGNOSIS, PATHOPHYSIOLOGY AND CLINICAL COURSE OF RAYNAUD'S SYNDROME
NATURAL HISTORY OF RAYNAUD'S SYNDROME
NATURAL HISTORY OF RAYNAUD'S SYNDROME